Medical Director, Data Generation
enGene
·Yesterday
- Salary
- $270k – $310k/yr
- Location
- Boston, MA
- Workplace
- Hybrid
- Type
- Full-time
- Department
- Medical Affairs
- Seniority
- Director
- Education
- PhD
- Source
- Lever
Description
OPENING
enGene (NASDAQ: ENGN) is a late-stage biotechnology company, mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.
ROLE
The Medical Director, Data Generation will lead the development and execution of Medical Affairs evidence-generation strategy for detalimogene voraplasmid and future enGene programs. This individual will translate scientific, clinical and stakeholder knowledge gaps into an integrated evidence plan that supports launch readiness, advances understanding of the evolving NMIBC treatment paradigm and generates clinically meaningful evidence for patients, healthcare professionals, payers and other decision-makers.
Reporting to the Vice President, Medical Affairs, this role will partner closely with Clinical Development, Biostatistics, Regulatory, HEOR/Market Access, Scientific Communications, Field Medical, Medical Excellence and external experts. The successful candidate will provide hands-on scientific leadership across evidence planning, study design, execution, analysis and dissemination in a fast-paced biotechnology environment.